BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22226343)

  • 1. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2011 Mar; 65(3):330-40. PubMed ID: 21199198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
    Kwentus J; Riesenberg RA; Marandi M; Manning RA; Allen MH; Fishman RS; Spyker DA; Kehne JH; Cassella JV
    Bipolar Disord; 2012 Feb; 14(1):31-40. PubMed ID: 22329470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
    Lesem MD; Tran-Johnson TK; Riesenberg RA; Feifel D; Allen MH; Fishman R; Spyker DA; Kehne JH; Cassella JV
    Br J Psychiatry; 2011 Jan; 198(1):51-8. PubMed ID: 21200077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Montañés F; Dobrovolskaya N; Bukhanovskaya O; Popov M; Vieta E
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):710-718. PubMed ID: 29724638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy review of inhaled loxapine for treatment of agitation.
    Currier G; Walsh P
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):25-32. PubMed ID: 23538290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.
    de Berardis D; Fornaro M; Orsolini L; Iasevoli F; Tomasetti C; de Bartolomeis A; Serroni N; Valchera A; Carano A; Vellante F; Marini S; Piersanti M; Perna G; Martinotti G; Di Giannantonio M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.
    Pollack CV
    Curr Med Res Opin; 2016 Jul; 32(7):1253-60. PubMed ID: 27121764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial.
    Gil E; Garcia-Alonso F; Boldeanu A; Baleeiro Teixeira T;
    BMJ Open; 2018 Oct; 8(10):e020242. PubMed ID: 30282677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.
    Keating GM
    CNS Drugs; 2013 Jun; 27(6):479-89. PubMed ID: 23740380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
    Gross N; Greos LS; Meltzer EO; Spangenthal S; Fishman RS; Spyker DA; Cassella JV
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):478-87. PubMed ID: 24745666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.